Alexion Pharmaceuticals Claimed Company
Medicine/ Drug Developer and distributor read more
HR or Marketing? Claim Your Free Employer Account
Alexion Pharmaceuticals VP of Investor Relations Salary
The average Alexion Pharmaceuticals VP of Investor Relations earns an estimated $125,500 annually. Alexion Pharmaceuticals' VP of Investor Relations compensation is $5,908 less than the US average for a VP of Investor Relations.
Last updated 2 years ago.
$77k
$120k
$129k
$225k
$125,500
Average Compensation
- $125,500
- avg. base
VP of Investor Relations Salaries at Alexion Pharmaceuticals
Compensation at Alexion Pharmaceuticals by Department
How VPs of Investor Relations at Alexion Pharmaceuticals Rate Their Compensation
The majority of VPs of Investor Relations at Alexion Pharmaceuticals believe they're compensated fairly. 100% of VPs of Investor Relations at Alexion Pharmaceuticals say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at Alexion Pharmaceuticals
VP of Investor Relations Salaries at Similar Size Companies
×